$447 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 45.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EHC | Buy | ENCOMPASS HEALTH CORP | $45,334,000 | +33.1% | 697,659 | +26.8% | 10.13% | +18.1% |
ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $29,951,000 | +258.5% | 220,000 | +214.3% | 6.69% | +218.1% |
CRL | CHARLES RIV LABS INTL INC | $29,439,000 | +29.9% | 130,000 | 0.0% | 6.58% | +15.3% | |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $27,188,000 | +12.2% | 350,000 | -19.7% | 6.08% | -0.5% |
CTLT | CATALENT INC | $23,985,000 | +16.9% | 280,000 | 0.0% | 5.36% | +3.7% | |
HOLX | Sell | HOLOGIC INC | $23,785,000 | -16.5% | 357,833 | -28.4% | 5.32% | -25.9% |
BSX | BOSTON SCIENTIFIC CORP | $22,926,000 | +8.8% | 600,000 | 0.0% | 5.12% | -3.4% | |
NVRO | Buy | NEVRO CORP | $22,288,000 | +24.0% | 160,000 | +6.3% | 4.98% | +10.0% |
IQV | Buy | IQVIA HLDGS INC | $22,068,000 | +13.1% | 140,000 | +1.8% | 4.93% | +0.3% |
PACB | New | PACIFIC BIOSCIENCES CALIF IN | $19,740,000 | – | 2,000,000 | +100.0% | 4.41% | – |
DVA | New | DAVITA INC | $18,843,000 | – | 220,000 | +100.0% | 4.21% | – |
GH | Buy | GUARDANT HEALTH INC | $18,555,000 | +38.2% | 166,000 | +0.3% | 4.15% | +22.6% |
MOH | MOLINA HEALTHCARE INC | $18,304,000 | +2.8% | 100,000 | 0.0% | 4.09% | -8.7% | |
INOV | Sell | INOVALON HLDGS INC | $17,193,000 | +21.8% | 650,000 | -11.3% | 3.84% | +8.0% |
SGRY | Buy | SURGERY PARTNERS INC | $16,425,000 | +109.8% | 750,000 | +10.8% | 3.67% | +86.1% |
ANTM | New | ANTHEM INC | $16,115,000 | – | 60,000 | +100.0% | 3.60% | – |
AXNX | Sell | AXONICS MODULATION TECHNOLOG | $15,475,000 | +26.8% | 303,201 | -12.8% | 3.46% | +12.5% |
VCEL | New | VERICEL CORP | $10,747,000 | – | 580,000 | +100.0% | 2.40% | – |
BMY | Sell | BRISTOL-MYERS SQUIBB CO | $9,044,000 | -46.5% | 150,000 | -47.9% | 2.02% | -52.6% |
INSP | Sell | INSPIRE MED SYS INC | $9,034,000 | -10.5% | 70,000 | -39.7% | 2.02% | -20.6% |
TWST | Sell | TWIST BIOSCIENCE CORP | $7,597,000 | -60.1% | 100,000 | -76.2% | 1.70% | -64.6% |
OM | New | OUTSET MED INC | $7,500,000 | – | 150,000 | +100.0% | 1.68% | – |
NVST | Sell | ENVISTA HOLDINGS CORPORATION | $7,404,000 | -29.8% | 300,000 | -40.0% | 1.66% | -37.7% |
BLFS | New | BIOLIFE SOLUTIONS INC | $4,341,000 | – | 150,000 | +100.0% | 0.97% | – |
RPRX | ROYALTY PHARMA PLC | $4,207,000 | -13.3% | 100,000 | 0.0% | 0.94% | -23.1% | |
ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -150,000 | -100.0% | -1.83% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -200,000 | -100.0% | -2.96% | – |
CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -1,147,800 | -100.0% | -3.24% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -85,000 | -100.0% | -3.28% | – |
BAX | Exit | BAXTER INTL INC | $0 | – | -330,000 | -100.0% | -7.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
ICON PLC | 10 | Q3 2023 | 11.7% |
BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
NEVRO CORP | 10 | Q1 2022 | 6.7% |
DEXCOM INC | 10 | Q3 2023 | 7.7% |
ABBVIE INC | 9 | Q3 2023 | 8.1% |
ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.